I completed my PhD in 2013 at Newcastle University looking at biomarkers of cognitive impairment in Parkinson’s disease. I am now an NIHR BRC Intermediate Clinical Fellow at the Translational and Clinical Research Institute, Newcastle University; Deputy Director of the Clinical Ageing Research Unit; and Honorary Consultant in Older People’s Medicine at Newcastle upon Tyne Hospitals (NuTH) NHS Foundation Trust. I have a particular interest in cognitive decline, gait and falls in people with Parkinson’s and other neurodegenerative diseases and have published more than 60 articles in this topic area. I run a specialist clinic for older adults with Parkinson’s and complex health needs in NuTH, in addition to a general medical memory clinic.
Lawson RA, Williams-Gray CH, Camacho M, Duncan GW, Khoo TK, Breen DP, Barker RA, Rochester L, Burn DJ, Yarnall AJ. Which neuropsychological tests? Cognitive decline and predictors of dementia in Parkinson’s disease in the ICICLE-PD cohort. Accepted, Journal of Parkinson’s Disease, 22nd May 2021.
Naisby J, Lawson RA, Galna B, Alcock L, Burn DJ, Rochester L, Yarnall AJ. Trajectories of pain over six years in early Parkinson’s disease: ICICLE-PD. Accepted, J Neurology, April 2021.
McArdle R, Del Din S, Yarnall AJ. Gait analysis as a clinical tool for dementia: current perspectives and future challenges. Acccepted, Advances in Clinical Neuroscience and Rehabilitation, January 2021.
Del Din S, Kirk C, Yarnall AJ, Rochester L, Hausdorff JM. Body-worn Sensors for Remote Monitoring of Parkinson’s disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead. J Parkinson’s Disease, 2021. DOI 10.3233/JPD-202471.
Wilson J, Yarnall AJ, Craig CE, Galna B, Lord S, Morris R, Lawson RA, Alcock L, Duncan GW, Khoo TK, O’Brien JT, Burn DJ, Taylor JP, Ray NJ, Rochester L (2021). Cholinergic basal forebrain volumes predict gait decline in early Parkinson’s disease. Movement Disorders, DOI: 10.1002/mds.28453.
Current grants from Michael J Fox Foundation, Intercept Pharmaceuticals, Lewy Body Society, Weston Brain Institute, Parkinson’s UK, Dunhill Medical Trust, NIHR HTA, and EU IMI
